A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life
Phase
N/ASpan
305 weeksSponsor
Nutricia ResearchBeek
Recruiting
Healthy Volunteers
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
Phase
3Span
300 weeksSponsor
Chiesi Farmaceutici S.p.A.Beek
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Phase
3Span
249 weeksSponsor
AstraZenecaBeek
Recruiting
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Phase
3Span
219 weeksSponsor
Hoffmann-La RocheBeek
Recruiting
1-4 of 4